Condition: Stroke · Hemorrhagic Stroke · Sponsor: EMVision Medical Devices Ltd
The purpose of this research is to evaluate a new investigational device for the diagnosis of stroke, the EMVision emu™ Brain Scanner. Stroke is the result of a blood clot stopping the normal flow of blood in the brain (ischaemic stroke) or a breakage in a blood vessel causing bleeding in the brain (haemorrhagic stroke). Stroke is a medical emergency and must be quickly diagnosed and treated. Computed tomography (CT) or magnetic resonance imaging (MRI) scans are commonly used to diagnose stroke, but they are not always readily available. EMVision has developed the emu™ Brain Scanner, a helmet-like device which scans the head using ultra-high frequency radio signals. It is portable and easy to use, making it more accessible than CT or MRI machines. Easier access to the EMVision emu™ Brain Scanner may reduce the time taken to diagnose stroke, leading to faster treatment and better health outcomes. It is the purpose of this study in the first instance to determine the accuracy of the EMVision emu™ Brain Scanner in the detection of haemorrhagic stroke.
This description comes directly from the study's public registry record.
Christian Wight, PhD · 61 (0) 490 109 797 · cwight@emvision.com.au
Sadie Burnham · 7742078910 · sburnham@vastrax.com
Always discuss trial participation with your own doctor first.
| UCLA | Los Angeles, California, United States | Recruiting |
| Mayo Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Mount Sinai West | New York, New York, United States | Recruiting |
| Mount Sinai Health System | New York, New York, United States | Recruiting |
| Memorial Hermann Memorial City Medical Center | Houston, Texas, United States | Recruiting |
| UTHealth | Houston, Texas, United States | Recruiting |
| Liverpool Hospital | Liverpool, New South Wales, Australia | Recruiting |
| Royal Melbourne Hospital | Parkville, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06999122